- Home
- ESP vs OBIO Comparison
ESP vs OBIO Comparison
Compare ESP & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESP | OBIO |
|---|---|---|
| Founded | 1928 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 172.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ESP | OBIO |
|---|---|---|
| Price | $42.53 | $4.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 13.6K | ★ 342.3K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | ★ $42,600,530.00 | $2,818,000.00 |
| Revenue This Year | $9.16 | $36.43 |
| Revenue Next Year | $5.68 | $2.56 |
| P/E Ratio | $13.45 | ★ N/A |
| Revenue Growth | 4.90 | ★ 6.46 |
| 52 Week Low | $24.85 | $2.20 |
| 52 Week High | $55.00 | $6.30 |
Technical Indicators
Market Signals| Indicator | ESP | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 71.26 | 50.32 |
| Support Level | $38.07 | $4.15 |
| Resistance Level | $39.84 | $5.42 |
| Average True Range (ATR) | 1.41 | 0.39 |
| MACD | 0.49 | -0.06 |
| Stochastic Oscillator | 88.45 | 34.22 |
Price Performance
Historical ComparisonAbout ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.